BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 30006588)

  • 1. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment.
    Di Virgilio F; Sarti AC; Falzoni S; De Marchi E; Adinolfi E
    Nat Rev Cancer; 2018 Oct; 18(10):601-618. PubMed ID: 30006588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of purinergic P2X
    McLarnon JG
    Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
    Zhang WJ; Hu CG; Zhu ZM; Luo HL
    Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.
    Bianchi G; Vuerich M; Pellegatti P; Marimpietri D; Emionite L; Marigo I; Bronte V; Di Virgilio F; Pistoia V; Raffaghello L
    Cell Death Dis; 2014 Mar; 5(3):e1135. PubMed ID: 24651438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP in the tumour microenvironment drives expression of nfP2X
    Gilbert SM; Oliphant CJ; Hassan S; Peille AL; Bronsert P; Falzoni S; Di Virgilio F; McNulty S; Lara R
    Oncogene; 2019 Jan; 38(2):194-208. PubMed ID: 30087439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
    Scarpellino G; Genova T; Munaron L
    Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic receptors: new targets for the treatment of gout and fibrosis.
    Gicquel T; Le Daré B; Boichot E; Lagente V
    Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular ATP: A Feasible Target for Cancer Therapy.
    Vultaggio-Poma V; Sarti AC; Di Virgilio F
    Cells; 2020 Nov; 9(11):. PubMed ID: 33212982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ATP-P2X
    Wang-Fang J; Chun-Jie J; Fei G; Jia-Hui L; Ming L
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Jul; 29(4):526-529. PubMed ID: 29508600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
    Kan LK; Seneviratne S; Drummond KJ; Williams DA; O'Brien TJ; Monif M
    Purinergic Signal; 2020 Sep; 16(3):327-336. PubMed ID: 32583309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells.
    Wilkaniec A; Gąssowska M; Czapski GA; Cieślik M; Sulkowski G; Adamczyk A
    Purinergic Signal; 2017 Sep; 13(3):347-361. PubMed ID: 28516276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The P2X7 Receptor in Infection and Inflammation.
    Di Virgilio F; Dal Ben D; Sarti AC; Giuliani AL; Falzoni S
    Immunity; 2017 Jul; 47(1):15-31. PubMed ID: 28723547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic receptors in embryonic and adult neurogenesis.
    Oliveira Á; Illes P; Ulrich H
    Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2 receptors in cancer progression and metastatic spreading.
    Di Virgilio F; Falzoni S; Giuliani AL; Adinolfi E
    Curr Opin Pharmacol; 2016 Aug; 29():17-25. PubMed ID: 27262778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic Signaling Within the Tumor Microenvironment.
    Draganov D; Lee PP
    Adv Exp Med Biol; 2021; 1270():73-87. PubMed ID: 33123994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of P2X7 purinergic receptor activity by extracellular Zn
    Kovács G; Környei Z; Tóth K; Baranyi M; Brunner J; Neubrandt M; Dénes Á; Sperlágh B
    Cell Calcium; 2018 Nov; 75():1-13. PubMed ID: 30098501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine regulation of TGF-β1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells.
    Takai E; Tsukimoto M; Harada H; Sawada K; Moriyama Y; Kojima S
    J Cell Sci; 2012 Nov; 125(Pt 21):5051-60. PubMed ID: 22946048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2 receptor networks regulate signaling duration over a wide dynamic range of ATP concentrations.
    Grol MW; Pereverzev A; Sims SM; Dixon SJ
    J Cell Sci; 2013 Aug; 126(Pt 16):3615-26. PubMed ID: 23750003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice.
    Domingos LB; Hott SC; Terzian ALB; Resstel LBM
    Neuropharmacology; 2018 Jan; 128():474-481. PubMed ID: 28802645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.